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Edited by Ivan SadowskiAbstract DNp63a is exclusively expressed in stem cells and
progenitor cells of the stratiﬁed epithelia. It promotes cell prolif-
eration by antagonizing p53 and related TAp63/TAp73. Here,
we report that speciﬁc desumoylation by SUMO protease
SuPr-1 provides a ﬁne-tuning mechanism for DNp63a repressor
activity. We found that disrupting the sumoylation site compro-
mised DNp63a repressor activity profoundly against TAp63c
and TAp73b-mediated transcription activation, but not to p53-
mediated transcription. We further found that SuPr-1 speciﬁ-
cally bound to sumoylated DNp63a and hydrolyzed SUMO.
Consequently, SuPr-1 expression reduced DNp63a repressor
activity to TAp63c and TAp73b, whereas p53-mediated transac-
tivation was unaﬀected. Collectively, these data suggest that
SuPr-1-mediated DNp63a desumoylation elaborately regulates
epithelial growth.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The p63gene(AIS/KET/CUSP/p40/p51/p73L) encodes two
diﬀerent transcripts. One transcript encodes TAp63, which is
structurally and functionally similar to p53. DNp63, which
lacks most of the transcription-activating domain of TAp63,
is directed by an internal intronic promoter [1]. In addition,
alternative splicing at the C-terminus generates at least three
splice variants—a, b, and c; the a form is the longest and con-
tains the sterile alpha motif and transcription inhibition do-
main [2,3]. Among the diﬀerent isotypes, DNp63a is
exclusively expressed in the epidermal stem cells and progeni-
tor cells, and required for epidermal development and for the
maintenance and regeneration of epidermal stem cells and pro-
genitor cells [4–6].
Although ﬁrst thought that DNp63a mainly acts as a domi-
nant-negative form for p53 and TAp63 in vitro and in vivo, re-
cent ﬁndings also suggest that DNp63a retains transcription
activation capacity as well and activates key target genes re-
quired for epidermal morphogenesis [4]. However, DNp63a*Corresponding author. Fax: +82 2 886 4335.
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proliferation during zebraﬁsh embryogenesis [5,6]: scheduled
overexpression in zebraﬁsh embryos suggested that DNp63a
antagonizes p53 for epidermal outgrowth. Thus, it appears
that the repressor function of DNp63a is essential, and there-
fore may be conserved, for maintaining epidermal cell prolifer-
ation in vertebrates [6].
DNp63a is a highly modiﬁed protein whose ubiquitination,
phosphorylation, sumoylation, have been reported: poly-ubiq-
uitination of DNp63a induces proteasome-mediated degrada-
tion [7] and SUMO modiﬁcation of K637 residue of TAp63a
(K582 for DNp63a) was reported to decrease transcription
activation function [8–10]. In the case of DNp63a, sumoyla-
tion, as well as neddylation, induced the degradation of the
protein during zebraﬁsh embryogenesis [8].
We were speciﬁcally interested in understanding the eﬀect of
sumoylation–desumoylation in regulating DNp63a’s repressor
activity, since it is conserved from ﬁsh to humans and is crucial
in the proliferation and survival of epithelial cell [5,6,11,12].
Here, we report that SuPr-1 functions as a speciﬁc SUMO pro-
tease for DNp63a, and regulates the repressor activity towards
TAp63c- and TAp73b-mediated transactivation. Our study
suggests that the sumoylation–desumoylation switch provides
a ﬁne-tuning regulatory mechanism for DNp63a-mediated
transcription control.2. Results
2.1. Conﬁrmation of DNp63a sumoylation at lysine 582
In order to assess the eﬀect of sumoylation that aﬀects
DNp63a repressor function, we substituted ﬁve potential
sumoylation consensus motifs with high probability (K494
and K582) and low probability (K139, K259, and K275) lysine
residues with arginine residues using in vitro mutagenesis and
constructed mutant DNp63a expression vectors.
Next, various mutant DNp63a expression constructs tagged
with Myc epitope at the N-termini were cotransfected into
293T cells with GFP-SUMO expression plasmids, then sub-
jected to immunoprecipitation followed by Western analysis.
Wild-type DNp63a and the other mutants were eﬃciently
sumoylated, whereas K582R mutant or the double mutant
(K582 and K494 substituted to arginine) were not (Fig. 1A).
This conﬁrmed that K582 (K647 for TAp63a) is the sumoyla-
tion site [8–10].
Sumoylation of DNp63a at the K582 site was further con-
ﬁrmed by immunoprecipitation and Western blotting with ablished by Elsevier B.V. All rights reserved.
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Fig. 1. DNp63a is sumoylated at K582. (A) 293T cells transfected with
various Myc-DNp63a expression plasmids with or without GFP-
SUMO-1 were subjected to immunoprecipitation (IP) with anti-Myc
mAb (9E10) and Western blotting (WB) with anti-GFP antibody.
Mono-sumoylation bands are indicated with an arrow. Slow-migrating
forms above the mono-sumoylated band, presumably the result of
polysumoylation, are also detected. The same blot was reprobed with
9E10 for normalization. (B) 293T cells transfected with Myc-DNp63a
(left panel) or ME180 cells without transfection (right panel) were
immunoprecipitated with 4A4 anti-p63 mAb and immunoblotted with
anti-SUMO-1 (GMP-1) mAb. Arrows indicate sumoylated DNp63a
and non-sumoylated forms are marked with asterisks. The same blot
was reprobed with 4A4 for immunoprecipitation control. Immuno-
precipitation with mouse IgG (mIg) was included as a negative control
(right panel). (C) Transcription inhibition domains of zebraﬁsh,
mouse, and human DNp63a are aligned. K582 sumoylation motif
(underlined) and mutations found in human patients with split-hand–
split-foot malformation are also highlighted.
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detected by anti-SUMO antibodies, whereas the K582R mu-
tant remained undetected (Fig. 1B, left panel). We then asked
whether endogenous DNp63a was also sumoylated by employ-
ing ME180 cervical carcinoma cell line that expresses DNp63a.
From immunoprecipitation followed by immunoblotting with
anti-SUMO antibody, we conﬁrmed that endogenous DNp63a
undergoes sumoylation (Fig. 1B, right panel). In addition, a
slower migrating band corresponding to the sumoylated
DNp63a was readily detected for wild-type DNp63a but not
for the K582R mutant (Fig. 1B, bottom panels). These com-
bined results conﬁrmed that DNp63a is sumoylated at K582
in vivo. Notably, K582 resides in the transcription inhibition
domain at the extreme C-terminus [3], which is conserved from
ﬁsh to humans (Fig. 1C). Interestingly, mutations associated
with the epidermal syndrome split-hand–split-foot malforma-
tion, Q579X (634 for TAp63) [13] and E584X (639 for
TAp63), lie adjacent to K582 or directly aﬀect K582 sumoyla-
tion [10]. Since DNp63a is responsible for epidermal develop-ment among diﬀerent p63 isotypes [4–6], these results imply
that K582 sumoylation in DNp63a may have an essential func-
tion in modulating DNp63a activity in epidermal homeostasis
[10].2.2. Sumoylation controls transcription repression of DNp63a
In order to explore the outcome of sumoylation on the tran-
scriptional repressor function of DNp63a, we adopted a lucif-
erase reporter assay. In order to assess the transcription
activation by all three p53 family members, we employed a
luciferase reporter construct linked to a putative p53-respon-
sive element (PG13-Luc). All three constructs activated
PG13, with TAp63c to the highest level (70-fold compared
to 10-fold for p53). DNp63a acted as a strong repressor in a
dose-dependent manner, with the eﬀect most profound for
p53, then to TAp73b-mediated transactivation. For similar
repression levels, greater amounts of DNp63a were required
for TAp63c-mediated transcription (Fig. 2A). In comparison,
the repressor activity of sumoylation-defective mutant
K582R was compromised; greatly aﬀecting TAp73b and
TAp63c, but less so to p53. When we compared the repressor
activity of WT or K582R mutant on p53/TAp63/TAp73 target
genes, we conﬁrmed that the endogenous mRNA levels of p21
and Bax were repressed by wild-type but less so by K582R mu-
tant (Fig. 2B), consistent with the reporter analyses (Fig. 2A).
The decreased repressor activity of K582R mutant can result
from changes in protein stability or cellular localization. In or-
der to test whether sumoylation/desumoylation aﬀects nuclear
localization, we performed Western analysis after biochemical
fractionation in U2OS cells transfected with wild-type DNp63a
or K582R encoding plasmids. The result showed that there was
little diﬀerence in protein levels or nuclear localization between
wild-type and sumoylation-defective mutant (Fig. 2C).
Next, we examined the DNp63a’s interaction aﬃnity to p53,
TAp63c, and TAp73b. Wild-type and K582R were bound to
all three p53 members. However, there was 2-fold decrease in
binding of K582R to TAp63c, and a slight decrease for
TAp73b, compared to that of the wild-type (Fig. 2D), whereas
the binding ability to p53 between the wild-type and K582R
was not diﬀerent. These results may account for the diﬀerence
between wild-type and K582R in the repressor activity towards
TAp63c-mediated transactivation. As DNp63a interacts with
number of transcription factors [14] (our unpublished data),
sumoylation may provide diﬀerential binding platform for
DNp63a.2.3. SUMO-1 protease SuPr-1 selectively reduces DNp63a
transcriptional repression
Because DNp63a sumoylation is readily detected under nor-
mal culture conditions, we speculated that desumoylation, may
be a controlling step in regulating repressor activity exerted by
DNp63a. Therefore, we asked if the SUMO-1-speciﬁc protease
SuPr-1 [15] or SENP-1 [16] would associate with DNp63a. As
shown in Fig. 3A (upper panel), there was a robust interaction
of slow-migrating DNp63a with catalytically inactive SuPr-1
(C466S) [15] but with a weak interaction to catalytically active
SuPr-1. These data suggest that SuPr-1 interacted with sumoy-
lated DNp63a and rapidly hydrolyzed SUMO-1. Desumoyla-
tion was conﬁrmed in that SuPr-1 hydrolyzed SUMO-1 from
DNp63a in a dose-dependent manner (Fig. 3B). In contrast,
the C466S mutant was unable to desumoylate DNp63a
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Fig. 2. Sumoylation modulates transcription repressor activity of DNp63a. (A) BHK21 cells were co-transfected with PG13-luc and pRL-TK to
assess transcription repressor function of DNp63a on p53-, TAp63c-, or TAp73b-mediated transcription. To compare the repressor activities of wild-
type (WT) vs. K582R DNp63a, varying amounts of repressor were employed and examined for their eﬀects. The ratios for transcription activator
(p53, TAp63c, or TAp73b) vs. repressor (DNp63a) were 20:1, 5:1, and 1:1, respectively. The y-axis shows the fold induction of ﬁreﬂy luciferase
activity normalized with renilla luciferase activity from cells transfected with reporter alone. Note that the values of fold induction in y axis for
TAp63c-mediated transcription are higher. Values are averages of duplicate transfections and represent six independent experiments. (B) U2OS cells
were transfected with WT or K582R mutant DNp63a, and real time RT-PCR was performed to check for the transcript levels of p21 and Bax. Levels
were normalized with GAPDH expression and control vector-transfected group. (C) U2OS cells were transfected with wild-type (WT) DNp63a or
K582R. Forty-eight hours post-transfection, cells were harvested and fractionated [23]. T, total cell lysates; CN, cytoplasmic and nuclear soluble
fraction; NS, nuclear soluble fraction; NP, nuclear pellet; Ch, nuclear pellet subjected to DNase digestion. (D) 293T cells cotransfected with Myc-
DNp63a (WT or K582R) and p53, TAp63c, or TAp73b expression plasmids were subjected to immunoprecipitation with anti-Myc mAb and Western
blotting with anti-p53, anti-p63, or anti-p73 mAbs (upper panels). The same blot was reprobed with anti-p63 antibody (4A4) as an
immunoprecipitation control (middle panels). Western blotting with anti-p53, anti-p63, or anti-p73 mAb in total cell lysates (TCL) indicates that
similar amounts of expression plasmids were expressed (lower panels).
5642 H. Lee et al. / FEBS Letters 581 (2007) 5640–5644(Fig. 3B). When we tested for SENP1, another SUMO prote-
ase, the result showed that DNp63a did not interact with
SENP1 (Fig. 3A, lower panel). These data suggest that SuPr-
1 serves as a speciﬁc SUMO protease for DNp63a and may
regulate its function.
The association of DNp63a and SuPr-1 was corroborated by
indirect immunoﬂuorescence microscopy. DNp63a colocalized
with ectopically expressed SuPr-1; wild-type DNp63a co-local-
ized with the enzymatically inactive SuPr-1, but less so with the
wild-type SuPr-1. Co-localization of sumoylation-defective
mutant K582R with catalytically inactive mutant SuPr-1 was
reduced compared to wild-type DNp63a (Fig. 4).
Does desumoylation, mediated by SuPr-1, inﬂuence the
repressor activity of wild-type DNp63a? Indeed, coexpression
of SuPr-1 weakened the repressor activity of wild-type
DNp63a to levels comparable to that of the K582R mutantto TAp63c- and TAp73b-mediated transactivation (Fig. 5).
Consistent with the result in Fig. 2A, repression of p53-med-
iated transcriptional activation was not inﬂuenced by SuPr-1
coexpression (Fig. 5, upper panel). Therefore, SuPr-1 is likely
to be involved in selectively regulating DNp63a repressor
activity to TAp63c or TAp73b. Taken together, these obser-
vations suggest that DNp63a interacts with SuPr-1, and the
ensuing desumoylation regulates the repressor activity of
DNp63a.3. Discussion
In this study, we found that SuPr-1 speciﬁcally desumoylates
DNp63a. Unlike numerous substrate-speciﬁc E3 ubiquityl-
ation ligases, only three types of SUMO ligases have been
AIP
:α
-
Fl
ag
TC
L
Flag-SuPr-1
Myc-ΔNp63α
 M +
 -  M + -  M +
 - 
 M + - 
 -  -  M +  M +
IB: α-Myc
α-Flag
α-Myc
α-Flag
*
IP
:α
-
Fl
ag
TC
L
Flag-Senp-1
Myc-ΔNp63α
IB: α-Myc
α-Flag
α-Myc
α-Flag
B
WB: α-Myc
IP
:α
-
M
yc
Myc-ΔNp63α
 WT   - Flag-SuPr-1 C466S
+    +    +    +
  - 
+    +    +    +
α-flag
α-actin
α-Sumo
α-Myc
 M +
 -  M + -  M +
 - 
 M + - 
 -  -  M +  M +
46
90
90
90
90
90
90
115
115
Sumoylated
Nonspecific
90
115
90
90
*
*
*
MW
MW
MW
Fig. 3. SuPr-1 associates with DNp63a and hydrolyzes SUMO. (A) 293T cells were cotransfected with Myc-DNp63a, wild-type (WT) or K582R
mutant, ﬂag-SuPr-1-encoding plasmids (WT or C466S mutant) or ﬂag-Senp1 (WT or C603S) as indicated. Forty-eight-hours post-transfection,
lysates were subjected to immunoprecipitation with anti-Flag mAb and Western blotting with anti-Myc mAb to determine binding between DNp63a
and SuPr-1 or SENP1. The arrow indicates sumoylated DNp63a bound to SuPr-1; the star designates the non-sumoylated form. DNp63a did not
bind to SENP1. The same blot was reprobed with anti-Flag mAb to normalize for immunoprecipitation. Western blotting for total cell lysates (TCL)
is also shown for transfection control. (B) 293T cells were cotransfected with Myc-DNp63a and ﬂag-SuPr-1, wild type (WT) or C466S expression
plasmids to test whether SuPr-1 is capable of desumoylating DNp63a. Forty-eight-hours post-transfection, cells were subjected to Western blotting
(upper panels) or immunoprecipitation with anti-Myc mAb and Western blotting with anti-SUMO mAb (lower panels). The arrow indicates
sumoylated DNp63a, which diminishes with increasing amounts of Flag-SuPr-1 expression.
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5644 H. Lee et al. / FEBS Letters 581 (2007) 5640–5644described in mammals: PIAS, RanBP2, and Pc2 [17].
Desumoylation, on the other hand, is mediated by SUMO-spe-
ciﬁc proteases called SENPs (sentrin-speciﬁc protease 1–7 in
mammals) [18]. We found SuPr-1 (the N-terminally truncated
SENP2 isoform), but not SENP1, interacted with DNp63a and
reduced repressor activity toward TAp63c and TAp73b. Inter-
estingly, repression of p53-mediated transcription activation
was not inﬂuenced by SuPr-1. These ﬁndings suggest that
SuPr-1-mediated desumoylation provides a means to diﬀeren-
tially regulate DNp63a repressor activity toward TAp63c/
TAp73b versus p53.
The crosstalk between p53 family members plays a critical
role in making decisions in cell fate. The balance between the
dominant-negative form of p53 family members and transacti-
vating members also controls tumor cell survival [19,20].
Moreover, recent discovery of DN forms of p53 [21] and inter-
play between p63 and p73 isoforms [22] add more complexity
to the p53 network to guarantee the existence of versatile reg-
ulatory mechanisms. Our study suggests that SuPr-1-mediated
desumoylation provides a ﬁne-tuning mechanism that favors
transcription repressor activity of DNp63a towards diﬀerent
p53 family members.4. Materials and methods
4.1. Immunoprecipitation and Western blotting
Cells were lysed in NETN buﬀer (150 mM NaCl, 1 mM EDTA,
20 mM Tris, pH 8.0, 0.5% NP-40) supplied with protease inhibitors
(1 mM PMSF, 1 lg/ml Aprotinin, 2 lg/ml Leupeptin, 1 lg/ml Pepsta-
tin A, 1 lg/ml NaOVa4; Roche, 125 lMNEM; Sigma). Chemilumines-
cence of Western blots was processed under LAS-3000 (Fuji Film,
Japan).
4.2. Reporter assay
All transfections were equalized with the pcDNA3-Myc vector for
an equal DNA quantity and normalized with luciferase activity with
pRL-TK. Luciferase activity was measured 48-h later using the Dual
Luciferase Assay System (Promega, Madison, WI).
4.3. Real-time PCR
The relative levels of BAX and p21 mRNAs were determined by
real-time quantitative PCR with SYBR (Applied Biosystems, Foster
City, CA) and normalized to GAPDH products. Primer sequences
were – p21 forward: AAGACCATGTGGACCTGT, p21 reverse:
GGTAGAAATCTGTCATGCTG, Bax forward: TGACATGTTTT-
CTGACGGCAAC, Bax reverse: GGAGGCTTGAGGAGTCTCAC-
C, GAPDH forward: GAAGGTGAAGGTCGGAGTC, GAPDH
reverse: GAAGATGGTGATGGGATTTC.
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